In recent trading session, Gilead Sciences, Inc (NASDAQ:GILD) saw 1.41 million shares changing hands at last check today with its beta currently measuring 0.27. Company’s recent per share price level of $101.71 trading at $1.37 or 1.37% at last check today assigns it a market valuation of $126.52B. That most recent trading price of GILD’s stock is at a discount of -17.94% from its 52-week high price of $119.96 and is indicating a premium of 38.97% from its 52-week low price of $62.07.
For Gilead Sciences, Inc (GILD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.84. Splitting up the data highlights that, out of 17 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 6 suggested the stock as a Hold whereas 11 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Gilead Sciences, Inc (NASDAQ:GILD) trade information
Upright in the green today for gaining 1.37%, in the last five days GILD remained trading in the green while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $101.71 price level, adding 2.82% to its value on the day. Gilead Sciences, Inc’s shares saw a change of 10.11% in year-to-date performance and have moved 4.95% in past 5-day. Gilead Sciences, Inc (NASDAQ:GILD) showed a performance of -3.02% in past 30-days.
Wall Street analysts have assigned a consensus price target of 126 to the stock, which implies a rise of 19.28% to its recent value today. Analysts have been projecting 83 as a low price target for the stock while placing it at a high target of 132. It follows that stock’s current price would jump 18.4% in reaching the projected high whereas dropping to the targeted low would mean a gain of 18.4% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -38.13% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 73.01% while estimates for its earnings growth in next 5 years are of 25.74%.
Gilead Sciences, Inc (NASDAQ:GILD)’s Major holders
BLACKROCK INC. is the top institutional holder at GILD for having 120.63 million shares of worth $8.28 billion. And as of 2024-06-30, it was holding 9.6738 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 115.26 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.2431 of outstanding shares, having a total worth of $7.91 billion.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 39.06 shares of worth $3.98 billion or 3.14% of the total outstanding shares. The later fund manager was in possession of 33.73 shares on Dec 31, 2024 , making its stake of worth around $3.44 billion in the company or a holder of 2.71% of company’s stock.
